Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Involved-site Radiation Therapy is Equally Effective and Less Toxic Than Involved-field Radiation Therapy in Patients Receiving Combined Modality Treatment for Early-stage Unfavorable Hodgkin Lymphoma-An Analysis of the Randomized Phase 3 HD17 Trial of the German Hodgkin Study Group.
Rosenbrock J, Kaul H, Oertel M, Celik E, Linde P, Fan J, Eichenauer DA, Bröckelmann PJ, von Tresckow B, Kobe C, Dietlein M, Fuchs M, Borchmann P, Eich HT, Baues C. Rosenbrock J, et al. Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00514-5. doi: 10.1016/j.ijrobp.2024.04.015. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38631539 Free article.
Involved Site Radiotherapy Extends Time to Premature Menopause in Infra-Diaphragmatic Female Hodgkin Lymphoma Patients - An Analysis of GHSG HD14- and HD17-Patients.
Rosenbrock J, Vásquez-Torres A, Mueller H, Behringer K, Zerth M, Celik E, Fan J, Trommer M, Linde P, Fuchs M, Borchmann P, Engert A, Marnitz S, Baues C. Rosenbrock J, et al. Front Oncol. 2021 May 25;11:658358. doi: 10.3389/fonc.2021.658358. eCollection 2021. Front Oncol. 2021. PMID: 34113567 Free PMC article.
Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial.
Baues C, Goergen H, Fuchs M, Rosenbrock J, Celik E, Eich H, Kobe C, Voltin CA, Engert A, Borchmann P, Marnitz S. Baues C, et al. Among authors: rosenbrock j. Int J Radiat Oncol Biol Phys. 2021 Nov 15;111(4):900-906. doi: 10.1016/j.ijrobp.2021.07.1697. Epub 2021 Aug 11. Int J Radiat Oncol Biol Phys. 2021. PMID: 34389407 Clinical Trial.
Potential synergy between radiotherapy and CAR T-cells - a multicentric analysis of the role of radiotherapy in the combination of CAR T cell therapy.
Fan J, Adams A, Sieg N, Heger JM, Gödel P, Kutsch N, Kaul D, Teichert M, von Tresckow B, Bücklein V, Goesmann G, Li M, Struve N, Trommer M, Linde P, Rosenbrock J, Celik E, Penack O, Stuschke M, Subklewe M, Belka C, von Bergwelt-Baildon M, Borchmann P, Marnitz S, Baues C. Fan J, et al. Among authors: rosenbrock j. Radiother Oncol. 2023 Jun;183:109580. doi: 10.1016/j.radonc.2023.109580. Epub 2023 Feb 25. Radiother Oncol. 2023. PMID: 36842663
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Behringer K, Mueller H, Goergen H, Thielen I, Eibl AD, Stumpf V, Wessels C, Wiehlpütz M, Rosenbrock J, Halbsguth T, Reiners KS, Schober T, Renno JH, von Wolff M, van der Ven K, Kuehr M, Fuchs M, Diehl V, Engert A, Borchmann P. Behringer K, et al. Among authors: rosenbrock j. J Clin Oncol. 2013 Jan 10;31(2):231-9. doi: 10.1200/JCO.2012.44.3721. Epub 2012 Nov 13. J Clin Oncol. 2013. PMID: 23150709 Free article.
Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma.
Baues C, Görgen H, Semrau R, Nast-Kolb B, Assenmacher K, Celik E, Morgenthaler J, Rosenbrock J, Trommer M, Houbois C, Kobe C, Kriz J, Engert A, Marnitz S. Baues C, et al. Among authors: rosenbrock j. Leuk Lymphoma. 2019 Dec;60(13):3244-3250. doi: 10.1080/10428194.2019.1623888. Epub 2019 Jun 22. Leuk Lymphoma. 2019. PMID: 31232136
Corrigendum to "Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial": Annals of Oncology 2012; 23: 1818-1825.
Behringer K, Thielen I, Mueller H, Goergen H, Eibl AD, Rosenbrock J, Halbsguth T, Eichenauer DA, Fuchs M, Reiners KS, Renno JH, van der Ven K, Kuehr M, von Wolff M, Diehl V, Engert A, Borchmann P. Behringer K, et al. Among authors: rosenbrock j. Ann Oncol. 2020 Aug;31(8):1093. doi: 10.1016/j.annonc.2020.05.020. Epub 2020 Jun 15. Ann Oncol. 2020. PMID: 32553542 Free article. No abstract available.
23 results